Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus  by Wei, Kevin et al.
JACC Vol. 26, No. 4 859 
October 1995:859-63 
Association Between QT Dispersion and Autonomic Dysfunction in 
Patients With Diabetes Mellitus 
KEVIN WEI, MD, PAUL  DORIAN,  MD, DAVID NEWMAN,  MD, FACC, 
ANATOLY LANGER,  MD, FACC 
Toronto, Ontario, Canada 
Objectives. We hypothesized that QT dispersion would be 
increased in patients with diabetes mellitus and autonomic dys- 
function and that QT dispersion would be related to abnormal 
iodine-123 (I-123) metaiodobenzylguanidine (MIBG) uptake. 
Background. Patients with diabetes mellitus and autonomic 
dysfunction have an increased incidence of sudden death. This 
event may be due to a sympathetic imbalance causing distur- 
bances of repolarization. QT dispersion has recently been dem- 
onstrated to reflect dispersion of ventricular efractoriness and is 
a marker of arrhythmogenic potential. Uptake of 1-123 MIBG is a 
reliable measure of whether the tissue examined receives sympa- 
thetic neuronal innervation. 
Methods. Fifty-one diabetic patients and 11 normal subjects 
were studied. All patients had clinical evaluation for autonomic 
dysfunction (defined as at least two abnormal heart rate and 
blood pressure responses to five validated tests). Rest 12-lead 
electrocardiograms were recorded for measurement of QT disper- 
sion, defined as the longest QT interval minus the shortest QT 
interval, and corrected for heart rate using Bazett's formula. 
Visual and quantitative measurements of 1-123 MIBG uptake 
were performed using 1-123 MIBG, and technetium-99m sesta- 
mibi uptake was used to assess perfusion. 
Results. Thirty-five diabetic patients had autonomic dysfunc- 
tion. Corrected QT dispersion was significantly greater in the 
patients than in the normal subjects (p = 0.02). The 1-123 MIBG 
scores were also significantly greater in patients with than without 
autonomic dysfunction (p = 0.0004) and in normal subjects (p = 
0.008). There was no correlation between QT dispersion and 1-123 
MIBG uptake score (r = 0.006, p = 0.97). 
Conclusions. Diabetic patients with autonomic dysfunction 
have increased QT dispersion and larger 1-123 MIBG uptake 
defects. This finding suggests that such patients have a greater 
iuhomogeneity of repolarization. The lack of correlation between 
QT dispersion and 1-123 MIBG uptake suggests that these 
abnormalities are mediated by different mechanisms. 
(J Am CoU Cardiol 1995;26:859- 63) 
The sympathetic nervous ystem is an important modulator of 
ventricular repolarization and is an important cofactor in the 
development of malignant ventricular arrhythmias. In addi- 
tion, acquired and congenital imbalances of sympathetic tone 
can result in disturbances of repolarization and have been 
postulated to be arrhythmogenic (1). Stimulation of intratho- 
racic sympathetic ganglia causes changes in indexes of repo- 
larization (2), and left stellate ganglion stimulation decreases 
the ventricular fibrillation threshold (3). By similar mecha- 
nisms, sympathetic imbalance may also be related to the 
pathophysiology of sudden death in patients with the familial 
long QT syndrome (4). More recently, the presence of QT 
dispersion on the 12-lead electrocardiogram (ECG) has been 
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shown to reflect dispersion f ventricular refractoriness (5) and 
has been demonstrated to be a marker of arrhythmogenic 
potential in the absence (6) or presence (7) of an acquired long 
QT interval. 
Diabetic patients with autonomic dysfunction have a worse 
prognosis (8), including an increased incidence of sudden 
death (9) than those with autonomic dysfunction. Given the 
relation between the sympathetic nervous ystem and arrhyth- 
mogenesis, such patients present a unique opportunity to 
evaluate sympathetic denervation and its arrhythmogenic po- 
tential. 
Conventionally, autonomic dysfunction has been assessed 
using standardized bedside maneuvers (10). More recently, 
iodine-123 (I-123) metaiodobenzylguanidine (MIBG), a nor- 
epinephrine analogue that shares the same uptake-1 mecha- 
nism into sympathetic nerve terminals, has been shown (11) to 
reflect reliably whether the tissue examined receives auto- 
nomic sympathetic neuronal innervation. 
We hypothesized that 1) QT dispersion would be increased 
in patients with diabetes mellitus and autonomic dysfunction, 
and 2) QT dispersion would be related to abnormal 1-123 
MIBG uptake. 
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Methods  
Patients. Fifty-one diabetic patients from the Diabetic 
Clinic at St. Michael's Hospital were nrolled in the study (36 
men, 15 women; mean [_+SD] age 54 +_ 11 years, range 31 to 
73) (12). In addition, 11 normal, nondiabetic men (mean age 
48 _+ 10 years, range 31 to 63) were recruited from the 
community for assessment ofQT dispersion and MIBG uptake 
abnormalities. All patients and control subjects were asymp- 
tomatic, had no history of cardiac disease and had normal 
results on physical examination. Comparison of baseline char- 
acteristics did not demonstrate any significant differences with 
regard to age (p = 0.13), gender (71% male vs. 100%, p = 
0.09), history ofsmoking (22% vs. 36%, p = 1.0), hypertension 
(31% vs. 22%, p = 0.5), hypercholesterolemia (46% vs. 45%, 
p = 0.2), hypertriglyceridemia (44% vs. 27%, p = 0.5) or 
obesity (18% vs. 0, p = I).3) between patients and control 
subjects, respectively. All patients and control subjects also had 
normal rest 12-lead ECG results. Patient medications included 
diuretic drugs (seven patients), centrally acting n adrenergic 
agents (two patients), calcium channel blocking agents (two 
patients), beta-adrenergic blocking age ts (four patients), an- 
giotensin-converting enzyme inhibitors (seven patients) and 
vasodilator agents (two patients). None of the control subjects 
was taking any medication. All medications were held at least 
5 half-lives before autonomic testing and 1-123 MIBG imaging. 
Autonomic function tests. Five validated and reproducible 
bedside maneuvers were p formed to define the presence of 
autonomic dysfunction. The presence of autonomic dysfunc- 
tion was defined as an abnormal response to two or more of 
the five tests, as previously reported (10). 1) Valsalva maneuver: 
The subject was asked to blow into a mouthpiece connected to 
a blood pressure sphygmomanometer at a pressure of 
40 mm Hg for 15 s. After this maneuver, the ratio of the 
longest o the shortest RR interval during the maneuver was 
measured (normal ->1.21). 2) Deep breathing: The subject 
breathed eeply and evenly at 6 breaths/rain. The mean 
difference between maximal and minimal heart rate during 
three successive breathing cycles was measured (normal >16 
beats/rain). 3) Response to standing: The ratio of the longest 
(the 30th beat) to the shortest RR interval (the 15th beat), that 
is, the 30:15 ratio, was calculated after the subject quickly 
changed from a supine to an upright position ( ormal ->1.04). 
4) Blood pressure response to standing: The difference in systolic 
blood pressure was measured with the subject supine and then 
immediately after the assumption of an upright posture (nor- 
mal response, decrease -< 11) mm Hg). 5) Sustained hand grip: 
The difference in diastolic blood pressure was measured after 
the subject was asked to maintain a hand grip at 30% of the 
maximal voluntary contraction with a hand-grip dynamometer 
for a maximum of 5 rain (normal response ->16 mm Hg). 
QT dispersion analysis, All diabetic patients and nondia- 
betic control subjects had a rest 12-lead ECG recorded at 
25-mm/s paper speed. All ECGs were interpreted by a single 
observer who was unaware of the results of autonomic function 
tests, the category of the patients and subjects, as well as the
results of 1-123 MIBG and sestamibi perfusion scans. The QT 
interval was defined as the interval from the onset of the QRS 
complex to the nd of the T wave, defined as a return to the TP 
baseline. Wherever possible, three consecutive cycles were 
measured in each of the 12 ECG leads. QT dispersion (the 
difference between the longest and shortest QT interval from 
any lead of a 12-lead ECG) was calculated using previously 
described methods (7). Both QT and QT dispersion were rate 
corrected using the modified Bazett's formula (1V~R) (13). 
Blinded intraobserver reproducibility of QT measurements 
was evaluated, and comparison revealed a Spearman correla- 
tion coefficient of 0.91 (p = 0.001). 
Nuclear studies. In the fasting state, all patients had 5 to 8 
mCi of 1-123 MIBG injected intravenously. A l subjects re- 
ceived 5 ml of 1% Lugol's solution 72 h before and 48 h after 
administration f 1-123 MIBG. Five hours after the injection, 8 
mCi of technetium-99m (Tc-99m) sestamibi was injected intra- 
venously. One hour later, dual-isotope tomographic maging 
was performed using an Elscint tomographic system with a 
general all-purpose collimator. Asymmetric windows of 15% at 
the 140- and 159-keV photopeaks were utilized for dual- 
isotope imaging. The windows were placed such that 10% of 
the window was utilized in the lower portion of the 140-keV 
photopeak and 10% in the upper portion of the 159-keV 
photopeak. Imaging was performed with the patient in the 
supine position, with 180 °continuous circular acquisition start- 
ing in the 45 o right anterior oblique position for 20 rain. Sixty 
images were acquired, with images stored in 3 ° increments in a 
64 × 64 matrix. Tomographic reconstruction was performed 
using a Butterworth filter with a cutoff of 0.35 in the fifth order. 
Short-axis, vertical long-axis and horizontal long-axis slices, 
each 1 pixel thick, were generated. 
Two physicians experienced in myocardial perfusion imag- 
ing interpreted all data and had no knowledge of the results of 
all other tests. The images were divided into 13 segments, and 
the uptake in each segment was scored from 0 (normal) to 4
(no uptake). To account for abnormal 1-123 MIBG uptake 
secondary to perfusion abnormalities, a corrected 1-123 MIBG 
defect score was generated by subtracting the sestamibi score 
from the 1-123 MIBG score on a segment-by-segment basis 
and then averaged for all 13 segments. 
The study protocol was approved by the St. Michael's 
Hospital Human Research Ethics Committee. All patients and 
subjects signed ethics committee-approved informed consent 
forms. 
Statistical analysis, Patients were grouped according to 
the presence or absence of autonomic dysfunction, and com- 
parisons were performed using analysis of variance and the 
Student unpaired t test for continuous data. Chi-square anal- 
ysis or the Fisher exact est (where appropriate) was used for 
discrete data. Correlational analysis was performed using 
standard linear regression methods with Spearman's rank 
correlation test. All data were expressed as mean value _+ SD. 
Statistical significance was set at p < 0.05. 
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Figure 1. Rate-corrected QT (QTc) dispersion i normal subjects and 
diabetic patients with (AD+) or without (AD)  autonomic dysfunc- 
tion on bedside tests. See text for full discussion. 
Resu l ts  
Autonomic function assessment. Clinical assessment of 
autonomic function in 51 patients with diabetes revealed 
abnormal responses to none of the maneuvers in 6 (12%), to 
one maneuver in 10 (20%), to two maneuvers in 20 (39%), to 
three maneuvers in 7 (14%), to four maneuvers in 5 (10%) and 
to all five maneuvers in 3 (6%). Thus, prospectively defined 
autonomic dysfunction (two or more abnormal responses) was 
present in 35 (69%) patients. In contrast, none of the control 
subjects was found to have autonomic dysfunction; five (455~) 
of the subjects had an abnormal response to one maneuver, 
and none of the others had any abnormal responses. 
QT dispersion analysis. Figure 1 shows the results of QT 
dispersion analysis. Both QT dispersion and corrected QT 
dispersion were significantly greater in patients with autonomic 
dysfunction than in normal subjects (53 + 19vs. 39 ± 9 ms, p - 
0.02; 60 +_ 20 vs. 42 _+ 11 ms, p < 0.02, respectively). There was 
a trend for QT dispersion and corrected QT dispersion to be 
greater in patients with than without autonomic dysfunction 
(53 _+ 19 vs. 45 ± 11 ms and 60 _+ 20 vs. 51 ± 14 ms, 
respectively, p = 0.06). No difference was found in either QT 
dispersion or corrected QT dispersion between patients with- 
out autonomic dysfunction and normal subjects (p = (I.4). The 
rate-corrected QT interval in lead II was similar in patients 
with (0.42 _+ 0.02 ms) and without autonomic dysfunction 
(0.43 _+ 0.03 ms) and in normal subjects (0.42 _+ 0.03 ms, p = 
0.45). 
Nuclear studies. The 1-123 MIBG scores in patients with 
and without autonomic dysfunction are shown in Figure 2. 
Patients with diabetes and autonomic dysfunction had a signif- 
icantly higher 1-123 MIBG score than those without autonomic 
dysfunction (19 _+ 15 vs. 8.6 ± 5, p = 0.0004) and normal 
subjects (19 ± 15 vs. 9.6 + 8, p - 0.008). The 1-123 MIBG 
score was not statistically different between diabetic patients 
without autonomic dysfunction and normal subjects (p = 0.7). 
Even though prospectively defined autonomic status was 
correlated with both 1-123 MIBG defects and QT dispersion, 
we found that 1-123 MIBG defects and QT dispersion were not 
correlated with each other. This finding is illustrated in Figure 
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Figure 2. Myocardial 1-123 metaiodobenzylguanidine (MIBG) score 
in normal subjects and diabetic patients with (AD+) and without 
(AD-) autonomic dysfunction on bedside tests. See text for full 
discussion. 
3; the correlation between corrected QT dispersion and 1-123 
MIBG defects is scattered, with r = 0.006, p = 0.97. A mild 
Tc-99m sestamibi perfusion defect involving at least 1 of the 13 
segments viewed was found in 21 of 51 patients and 5 of 11 
control subjects (p = NS). A separate analysis of absolute 
1-123 MIBG defect score (not corrected for perfusion) versus 
QT dispersion and corrected QT dispersion also showed no 
correlation. No correlation was found between Tc-99m sesta- 
mibi perfusion defect scores and QT dispersion or corrected 
QT dispersion. 
Discuss ion 
The principal finding of this study is that QT dispersion is 
significantly greater in patients with diabetes mellitus and 
autonomic dysfunction than in normal control subjects, and 
there was a trend for greater QT dispersion in diabetic patients 
with than without autonomic dysfunction. These findings sug- 
gest that diabetic patients with autonomic dysfunction have 
increased ispersion of ventricular efractoriness, which may 
Figure 3. Scattergram relation between 1-123 metaiodobenzylguani- 
dine (MIBG) score and rate-corrected QT (QTc) dispersion (r = 
0.006• p = 0.97). 
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be one of the factors contributing to the increased incidence of 
sudden death observed in these patients (9). These observa- 
tions also lend further support o previous studies (14) dem- 
onstrating that many subsets of patients with increased QT 
dispersion are at increased risk for sudden death. 
The presence of QT dispersion on the surface ECG as a 
marker of the dispersion of myocardial refractory properties 
has been validated (5) by measuring the monophasic a tion 
potential duration recorded at multiple left ventricular epicar- 
dial sites in humans. Increased QT dispersion has also been 
shown (7,15) to be a useful predictor of arrhythmia risk in 
congenital and acquired (drug induced) long QT syndrome. 
Recent studies have also shown thatQT dispersion increases 
after exercise, dobutamine or dipyridamole stress in patients 
with coronary artery disease (6) and is decreased with success- 
ful thrombolysis (6). To our knowledge, the present report is 
the first to evaluate of QT dispersion in patients with diabetes 
mellitus and autonomic dysfunction. 
The detection f autonomic dysfunction in diabetic patients 
previously relied on assessments of heart rate and blood 
pressure responses to various bedside maneuvers. Diminished 
heart rate variability was also demonstrated (16) to correlate 
with the presence of autonomic dysfunction in diabetes. Our
study extends those observations by demonstrating the pres- 
ence of greater abnormalities in 1-123 MIBG uptake in dia- 
betic patients with than those without autonomic dysfunction. 
The 1-123 MIBG defect score used in the present study was 
corrected for any Tc-99m sestamibi perfusion defects detected, 
so that 1-123 MIBG defects due to occult coronary artery 
disease or diabetes-related myopathic hanges were elimi- 
nated. Iodine-123 MIBG scanning offers additional dvantages 
over other approaches in that it also provides a quantitative 
assessment of the degree and localization of sympathetic 
denervation. 
The sympathetic nervous system plays a role in modulating 
dispersion of repolarization of the heart. Accordingly, we 
postulated that local cardiac sympathetic denervation would 
result in increased QT dispersion. This was notproved, and no 
correlation between QT dispersion and 1-123 MIBG uptake 
defects was found. One explanation for the lack of correlation 
between these two variables may be that repolarization and 
1-123 MIBG uptake defects are unrelated because central, 
rather than local (cardiac), abnormalities in sympathetic func- 
tion are responsible for the increase in QT dispersion. Such 
central control of QT dispersion could berelated to abnormal- 
ities of viable cardiac sympathetic nerves, which are known to 
deliver heterogeneous and regionally varied sympathetic input 
to the heart (17). We also found no correlation between the 
presence of Tc-99m sestamibi perfusion defects and QT dis- 
persion. This finding most likely relates to the fact that the 
perfusion defects in this cohort with a normal cardiac exami- 
nation and normal ECG results were v ry small. Furthermore, 
all perfusion scans were performed at rest, thus decreasing the 
likelihood that ischemia could affect QT dispersion. 
Limitations of the study. Some of the patients in the 
present study may have had silent myocardial ischemia. How- 
ever, all ECGs were recorded at rest, and it is unlikely that 
myocardial ischemia would have influenced QT dispersion. 
Measurement of the QT interval and QT dispersion is not 
standardized, and various investigators have used different 
definitions for the end ofthe T wave, especially in the presence 
of a U wave. Some have extrapolated the T wave back to the 
TP baseline, whereas others have measured the QT interval 
from the onset of the QRS complex to the nadir of the curve 
between the T and U waves. Some investigators have also 
excluded the limb leads from calculations of QT dispersion. In 
the present study, we used the methods originally described by 
Day et al. (7) and used by others (6). Furthermore, all 
measures were obtained in blinded manner by a single ob- 
server with a high intraobserver correlation. As a result, 
subjectivity in determining the end of repolarization on the 
ECG is uniform. 
Conclusions. Increased QT dispersion in diabetic patients, 
especially those with autonomic dysfunction suggests that such 
patients have a greater inhomogeneity of repolarization that 
may be of prognostic significance. W  found no correlation 
b tween QT dispersion and 1-123 MIBG uptake, suggesting 
that these two abnormalities are mediated by different mech- 
anisms. Further study is required to evaluate the relation 
between the sympathetic nervous system and ventricular repo- 
larization. 
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